Global colorectal cancer burden in 2020 and projections to 2040
- PMID: 34243011
- PMCID: PMC8273208
- DOI: 10.1016/j.tranon.2021.101174
Global colorectal cancer burden in 2020 and projections to 2040
Abstract
As the third most common malignancy and the second most deadly cancer, colorectal cancer (CRC) induces estimated 1.9 million incidence cases and 0.9 million deaths worldwide in 2020. The incidence of CRC is higher in highly developed countries, and it is increasing in middle- and low-income countries due to westernization. Moreover, a rising incidence of early-onset CRC is also emerging. The large number of CRC cases poses a growing global public health challenge. Raising awareness of CRC is important to promote healthy lifestyle choices, novel strategies for CRC management, and implementation of global screening programs, which are critical to reducing CRC morbidity and mortality in the future. CRC is a heterogeneous disease, and its subtype affiliation influences prognosis and therapeutic response. An accurate CRC subtype classification system is of great significance for basic research and clinical outcome. Here, we present the global epidemiology of CRC in 2020 and projections for 2040, review the major CRC subtypes to better understand CRC molecular basis, and summarize current risk factors, prevention, and screening strategies for CRC.
Keywords: Colorectal cancer; Epidemiology; Prevention; Projection; Risk factors.
Copyright © 2021. Published by Elsevier Inc.
Conflict of interest statement
None.
Figures
Similar articles
-
Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies.Nat Rev Gastroenterol Hepatol. 2019 Dec;16(12):713-732. doi: 10.1038/s41575-019-0189-8. Epub 2019 Aug 27. Nat Rev Gastroenterol Hepatol. 2019. PMID: 31455888 Review.
-
Tuberculosis.In: Holmes KK, Bertozzi S, Bloom BR, Jha P, editors. Major Infectious Diseases. 3rd edition. Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2017 Nov 3. Chapter 11. In: Holmes KK, Bertozzi S, Bloom BR, Jha P, editors. Major Infectious Diseases. 3rd edition. Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2017 Nov 3. Chapter 11. PMID: 30212088 Free Books & Documents. Review.
-
The role of artificial intelligence based systems for cost optimization in colorectal cancer prevention programs.Front Artif Intell. 2022 Sep 30;5:955399. doi: 10.3389/frai.2022.955399. eCollection 2022. Front Artif Intell. 2022. PMID: 36248620 Free PMC article. Review.
-
Temporal Trends in the Disease Burden of Colorectal Cancer with Its Risk Factors at the Global and National Level from 1990 to 2019, and Projections Until 2044.Clin Epidemiol. 2023 Jan 12;15:55-71. doi: 10.2147/CLEP.S388323. eCollection 2023. Clin Epidemiol. 2023. PMID: 36659904 Free PMC article.
-
Epidemiology and risk factors of colorectal cancer in China.Chin J Cancer Res. 2020 Dec 31;32(6):729-741. doi: 10.21147/j.issn.1000-9604.2020.06.06. Chin J Cancer Res. 2020. PMID: 33446996 Free PMC article.
Cited by
-
Quality of Life of Colorectal Cancer Patients: A Literary Review.Iran J Public Health. 2024 Jun;53(6):1236-1245. Iran J Public Health. 2024. PMID: 39430145 Free PMC article. Review.
-
Deciphering the potential role of post-translational modifications of histones in gastrointestinal cancers: a proteomics-based review with therapeutic challenges and opportunities.Front Oncol. 2024 Oct 21;14:1481426. doi: 10.3389/fonc.2024.1481426. eCollection 2024. Front Oncol. 2024. PMID: 39497715 Free PMC article. Review.
-
Oral Administration of Carotenoid-Rich Dunaliella salina Powder Inhibits Colon Carcinogenesis via Modulation of Wnt/β-catenin Signaling Cascades in a Rat Model.Appl Biochem Biotechnol. 2024 Aug 6. doi: 10.1007/s12010-024-05024-z. Online ahead of print. Appl Biochem Biotechnol. 2024. PMID: 39106028
-
Machine Learning Predicts Oxaliplatin Benefit in Early Colon Cancer.J Clin Oncol. 2024 May 1;42(13):1520-1530. doi: 10.1200/JCO.23.01080. Epub 2024 Feb 5. J Clin Oncol. 2024. PMID: 38315963
-
Generation of novel lipid metabolism-based signatures to predict prognosis and immunotherapy response for colorectal adenocarcinoma.Sci Rep. 2024 Jul 26;14(1):17158. doi: 10.1038/s41598-024-67549-x. Sci Rep. 2024. PMID: 39060344 Free PMC article.
References
-
- Dekker E., Tanis P.J., Vleugels J.L.A., Kasi P.M., Wallace M.B. Colorectal cancer. Lancet. 2019;394:1467–1480. - PubMed
-
- Guren M.G. The global challenge of colorectal cancer. Lancet Gastroenterol. Hepatol. 2019;4:894–895. - PubMed
-
- Schreuders E.H., Ruco A., Rabeneck L., Schoen R.E., Sung J.J., Young G.P., Kuipers E.J. Colorectal cancer screening: a global overview of existing programmes. Gut. 2015;64:1637–1649. - PubMed
-
- Rabeneck L., Chiu H.M., Senore C. International perspective on the burden of colorectal cancer and public health effects. Gastroenterology. 2020;158:447–452. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials